Senti Biosciences Holdings, Inc.
SNTI- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001854270
No open-market purchases or sales by Senti Biosciences Holdings, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $6.37M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Senti Biosciences Holdings, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- 0 vs. Q4 2024
- Shares held
- 5.92M
- +5.00M (+542.5%) vs. Q4 2024
- Total value
- $19.9M
- +$16.6M (+515.0%) vs. Q4 2024
- New holders
- 4
- 7 more added
- Sold out
- 4
- 0 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SNTI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 20 | $6.37M |
| Q1 2026 | 16 | $4.58M |
| Q4 2025 | 15 | $5.84M |
| Q3 2025 | 16 | $8.27M |
| Q2 2025 | 15 | $14.2M |
| Q1 2025 | 16 | $19.9M |
| Q4 2024 | 16 | $3.23M |
| Q3 2024 | 14 | $2.41M |
| Q2 2024 | 20 | $2.17M |
| Q1 2024 | 27 | $4.15M |
| Q4 2023 | 25 | $7.56M |
| Q3 2023 | 26 | $5.02M |
| Q2 2023 | 28 | $7.64M |
| Q1 2023 | 24 | $14.3M |
| Q4 2022 | 26 | $16.6M |
| Q3 2022 | 23 | $27.8M |
| Q2 2022 | 20 | $22.1M |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Senti Biosciences Holdings, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 3,775,615 | $12.7M | 0.98% | +3,333,000+753.0% | Added |
| Nantahala Capital Management, LLC | 888,000 | $2.98M | 0.25% | +888,000 | New |
| Heights Capital Management, Inc | 750,000 | $2.52M | 1.21% | +750,000 | New |
| 8VC GP I, LLC | 253,755 | $852.6K | 1.45% | 00.0% | Unchanged |
| Vanguard Group Inc | 154,136 | $517.9K | 0.00% | +56,669+58.1% | Added |
| UBS Group AG | 43,484 | $146.1K | 0.00% | +24,515+129.2% | Added |
| Geode Capital Management, LLC | 29,726 | $99.9K | 0.00% | +2,232+8.1% | Added |
| State Street Corp | 10,010 | $33.6K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 6,400 | $21.5K | 0.00% | +6,400 | New |
| BlackRock, Inc. | 4,004 | $13.5K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,425 | $4.79K | 0.00% | +402+39.3% | Added |
| SBI Securities Co., Ltd. | 338 | $1.14K | 0.00% | +1+0.3% | Added |
| Morgan Stanley | 160 | $538 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 126 | $423 | 0.00% | +6+5.0% | Added |
| Barclays PLC | 30 | $101 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 9 | $30 | 0.00% | +9 | New |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −51,600−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −13,356−100.0% | Sold out |
| ARK Investment Management LLCSuperinvestorARK Invest | 0 | $0 | 0.00% | −28−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |